Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Genomic and proteomic analyses of vascular endothelial growth factor and insulin-like growth factor-binding protein 3 in lung adenocarcinomas.

Gharib TG, Chen G, Huang CC, Misek DE, Iannettoni MD, Hanash SM, Orringer MB, Beer DG.

Clin Lung Cancer. 2004 Mar;5(5):307-12.

PMID:
15086970
2.

Reduced selenium-binding protein 1 expression is associated with poor outcome in lung adenocarcinomas.

Chen G, Wang H, Miller CT, Thomas DG, Gharib TG, Misek DE, Giordano TJ, Orringer MB, Hanash SM, Beer DG.

J Pathol. 2004 Mar;202(3):321-9.

3.

Protein profiles associated with survival in lung adenocarcinoma.

Chen G, Gharib TG, Wang H, Huang CC, Kuick R, Thomas DG, Shedden KA, Misek DE, Taylor JM, Giordano TJ, Kardia SL, Iannettoni MD, Yee J, Hogg PJ, Orringer MB, Hanash SM, Beer DG.

Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13537-42. Epub 2003 Oct 22.

4.

Increased C-CRK proto-oncogene expression is associated with an aggressive phenotype in lung adenocarcinomas.

Miller CT, Chen G, Gharib TG, Wang H, Thomas DG, Misek DE, Giordano TJ, Yee J, Orringer MB, Hanash SM, Beer DG.

Oncogene. 2003 Sep 11;22(39):7950-7.

PMID:
12970743
5.

Proteomic analysis of eIF-5A in lung adenocarcinomas.

Chen G, Gharib TG, Thomas DG, Huang CC, Misek DE, Kuick RD, Giordano TJ, Iannettoni MD, Orringer MB, Hanash SM, Beer DG.

Proteomics. 2003 Apr;3(4):496-504.

PMID:
12687616
6.

Overexpression of oncoprotein 18 correlates with poor differentiation in lung adenocarcinomas.

Chen G, Wang H, Gharib TG, Huang CC, Thomas DG, Shedden KA, Kuick R, Taylor JM, Kardia SL, Misek DE, Giordano TJ, Iannettoni MD, Orringer MB, Hanash SM, Beer DG.

Mol Cell Proteomics. 2003 Feb;2(2):107-16. Epub 2003 Feb 12.

7.

Proteomic analysis of cytokeratin isoforms uncovers association with survival in lung adenocarcinoma.

Gharib TG, Chen G, Wang H, Huang CC, Prescott MS, Shedden K, Misek DE, Thomas DG, Giordano TJ, Taylor JM, Kardia S, Yee J, Orringer MB, Hanash S, Beer DG.

Neoplasia. 2002 Sep-Oct;4(5):440-8.

8.

Gene-expression profiles predict survival of patients with lung adenocarcinoma.

Beer DG, Kardia SL, Huang CC, Giordano TJ, Levin AM, Misek DE, Lin L, Chen G, Gharib TG, Thomas DG, Lizyness ML, Kuick R, Hayasaka S, Taylor JM, Iannettoni MD, Orringer MB, Hanash S.

Nat Med. 2002 Aug;8(8):816-24. Epub 2002 Jul 15.

PMID:
12118244
9.

Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors.

Chen G, Gharib TG, Huang CC, Thomas DG, Shedden KA, Taylor JM, Kardia SL, Misek DE, Giordano TJ, Iannettoni MD, Orringer MB, Hanash SM, Beer DG.

Clin Cancer Res. 2002 Jul;8(7):2298-305.

10.

Discordant protein and mRNA expression in lung adenocarcinomas.

Chen G, Gharib TG, Huang CC, Taylor JM, Misek DE, Kardia SL, Giordano TJ, Iannettoni MD, Orringer MB, Hanash SM, Beer DG.

Mol Cell Proteomics. 2002 Apr;1(4):304-13.

Supplemental Content

Loading ...
Support Center